DK0922034T3 - Tetrahydroquinolinderivater som EAA-antagonister - Google Patents
Tetrahydroquinolinderivater som EAA-antagonisterInfo
- Publication number
- DK0922034T3 DK0922034T3 DK97943809T DK97943809T DK0922034T3 DK 0922034 T3 DK0922034 T3 DK 0922034T3 DK 97943809 T DK97943809 T DK 97943809T DK 97943809 T DK97943809 T DK 97943809T DK 0922034 T3 DK0922034 T3 DK 0922034T3
- Authority
- DK
- Denmark
- Prior art keywords
- tetrahydroquinoline derivatives
- eaa antagonists
- eaa
- antagonists
- tetrahydroquinoline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9617305.9A GB9617305D0 (en) | 1996-08-17 | 1996-08-17 | Heterocyclic compounds |
PCT/EP1997/004440 WO1998007704A1 (en) | 1996-08-17 | 1997-08-14 | Tetrahydroquinoline derivatives as eaa antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0922034T3 true DK0922034T3 (da) | 2002-11-18 |
Family
ID=10798623
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK97943809T DK0922034T3 (da) | 1996-08-17 | 1997-08-14 | Tetrahydroquinolinderivater som EAA-antagonister |
Country Status (34)
Country | Link |
---|---|
US (1) | US6479488B1 (cs) |
EP (1) | EP0922034B1 (cs) |
JP (1) | JP4108129B2 (cs) |
KR (1) | KR100552864B1 (cs) |
CN (1) | CN1131214C (cs) |
AP (1) | AP877A (cs) |
AR (1) | AR008296A1 (cs) |
AT (1) | ATE221052T1 (cs) |
AU (1) | AU724473B2 (cs) |
BR (1) | BR9711311B1 (cs) |
CA (1) | CA2264118C (cs) |
CO (1) | CO4900066A1 (cs) |
CZ (1) | CZ296250B6 (cs) |
DE (1) | DE69714265T2 (cs) |
DK (1) | DK0922034T3 (cs) |
EA (1) | EA001704B1 (cs) |
ES (1) | ES2181030T3 (cs) |
GB (1) | GB9617305D0 (cs) |
HU (1) | HU225797B1 (cs) |
ID (1) | ID18095A (cs) |
IL (1) | IL128141A0 (cs) |
IS (1) | IS4953A (cs) |
MY (1) | MY116952A (cs) |
NO (1) | NO312241B1 (cs) |
NZ (1) | NZ333812A (cs) |
PE (1) | PE107098A1 (cs) |
PL (1) | PL194532B1 (cs) |
PT (1) | PT922034E (cs) |
SI (1) | SI0922034T1 (cs) |
TR (1) | TR199900336T2 (cs) |
TW (1) | TW449582B (cs) |
WO (1) | WO1998007704A1 (cs) |
YU (1) | YU6799A (cs) |
ZA (1) | ZA977326B (cs) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9706294D0 (en) * | 1997-03-26 | 1997-05-14 | Glaxo Wellcome Spa | Heterocyclic compound |
MY125037A (en) * | 1998-06-10 | 2006-07-31 | Glaxo Wellcome Spa | 1,2,3,4 tetrahydroquinoline derivatives |
US6455734B1 (en) | 2000-08-09 | 2002-09-24 | Magnesium Diagnostics, Inc. | Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
GB9929037D0 (en) | 1999-12-08 | 2000-02-02 | Glaxo Wellcome Spa | Heterocyclic derivatives |
DE10132725A1 (de) | 2001-07-05 | 2006-08-03 | Grünenthal GmbH | Substituierte γ-Lactonverbindungen |
AU2002359875B2 (en) * | 2001-12-28 | 2009-01-08 | Acadia Pharmaceuticals Inc. | Tetrahydroquinoline analogues as muscarinic agonists |
US20050085463A1 (en) * | 2003-01-23 | 2005-04-21 | Weiner David M. | Use of N-desmethylclozapine to treat human neuropsychiatric disease |
RU2336879C2 (ru) * | 2003-01-23 | 2008-10-27 | Акадиа Фармасьютикалз Инк. | Применение n-десметилклозапина для лечения нейропсихиатрических заболеваний у людей |
US20050250767A1 (en) * | 2003-01-23 | 2005-11-10 | Weiner David M | Use of N-desmethylclozapine to treat human neuropsychiatric disease |
US20060233843A1 (en) * | 2003-02-19 | 2006-10-19 | Conn P J | Treatment of psychosis with a muscarinic m1 receptor ectopic activator |
JP2007534656A (ja) * | 2003-12-22 | 2007-11-29 | アカディア ファーマシューティカルズ,インコーポレーテッド | ムスカリンアゴニストとしてのアミノ置換ジアリール[a,d]シクロヘプテン類似体および精神神経疾患の治療方法 |
US20050282800A1 (en) * | 2004-04-01 | 2005-12-22 | Bo-Ragnar Tolf | Method of synthesis and isolation of solid N-desmethylclozapine and crystalline forms thereof |
KR101136183B1 (ko) | 2005-07-22 | 2012-04-17 | 모찌다 세이야쿠 가부시끼가이샤 | 신규 헤테로시클리덴 아세트아미드 유도체 |
RU2451014C2 (ru) * | 2005-07-22 | 2012-05-20 | Мотида Фармасьютикал Ко., Лтд. | Новое производное гетероциклиден ацетамида |
EP1966229B1 (en) | 2005-09-12 | 2015-10-21 | Abela Pharmaceuticals, Inc. | Systems for removing dimethyl sulfoxide (dmso) or related compounds, or odors associated with same |
WO2007033180A1 (en) | 2005-09-12 | 2007-03-22 | Abela Pharmaceuticals, Inc. | Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds |
US8480797B2 (en) | 2005-09-12 | 2013-07-09 | Abela Pharmaceuticals, Inc. | Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors |
US9427419B2 (en) | 2005-09-12 | 2016-08-30 | Abela Pharmaceuticals, Inc. | Compositions comprising dimethyl sulfoxide (DMSO) |
US20070105836A1 (en) * | 2005-10-31 | 2007-05-10 | Lars Pettersson | Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders |
BRPI0921494A2 (pt) | 2008-11-03 | 2018-10-30 | Prad Reasearch And Development Ltd | método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração. |
US9855212B2 (en) | 2009-10-30 | 2018-01-02 | Abela Pharmaceuticals, Inc. | Dimethyl sulfoxide (DMSO) or DMSO and methylsulfonylmethane (MSM) formulations to treat infectious diseases |
EP2763676B1 (en) | 2011-10-03 | 2019-12-25 | The University of Utah Research Foundation | Application of 5-ht6 receptor antagonists for the alleviation of cognitive deficits of down syndrome |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69029668T2 (de) | 1989-03-08 | 1997-08-07 | Merck Sharp & Dohme | Tetrahydroquinolin-Derivate, verwendbar bei neurodegenerativen Krankheiten |
DE69622731T2 (de) | 1995-09-29 | 2003-02-20 | Glaxosmithkline S.P.A., Verona | Tetrahydrochinoline als nmda antagonisten |
-
1996
- 1996-08-17 GB GBGB9617305.9A patent/GB9617305D0/en active Pending
-
1997
- 1997-08-14 CO CO97046782A patent/CO4900066A1/es unknown
- 1997-08-14 TR TR1999/00336T patent/TR199900336T2/xx unknown
- 1997-08-14 IL IL12814197A patent/IL128141A0/xx not_active IP Right Cessation
- 1997-08-14 EP EP97943809A patent/EP0922034B1/en not_active Expired - Lifetime
- 1997-08-14 JP JP51037298A patent/JP4108129B2/ja not_active Expired - Fee Related
- 1997-08-14 PL PL97331562A patent/PL194532B1/pl not_active IP Right Cessation
- 1997-08-14 MY MYPI97003742A patent/MY116952A/en unknown
- 1997-08-14 WO PCT/EP1997/004440 patent/WO1998007704A1/en active IP Right Grant
- 1997-08-14 PE PE1997000718A patent/PE107098A1/es not_active Application Discontinuation
- 1997-08-14 AR ARP970103703A patent/AR008296A1/es active IP Right Grant
- 1997-08-14 HU HU9903108A patent/HU225797B1/hu not_active IP Right Cessation
- 1997-08-14 SI SI9730404T patent/SI0922034T1/xx unknown
- 1997-08-14 YU YU6799A patent/YU6799A/sh unknown
- 1997-08-14 AP APAP/P/1999/001459A patent/AP877A/en active
- 1997-08-14 ID IDP972834A patent/ID18095A/id unknown
- 1997-08-14 KR KR1019997001280A patent/KR100552864B1/ko not_active IP Right Cessation
- 1997-08-14 CZ CZ0052999A patent/CZ296250B6/cs not_active IP Right Cessation
- 1997-08-14 DK DK97943809T patent/DK0922034T3/da active
- 1997-08-14 AT AT97943809T patent/ATE221052T1/de not_active IP Right Cessation
- 1997-08-14 ES ES97943809T patent/ES2181030T3/es not_active Expired - Lifetime
- 1997-08-14 NZ NZ333812A patent/NZ333812A/xx active Application Revival
- 1997-08-14 BR BRPI9711311-5A patent/BR9711311B1/pt not_active IP Right Cessation
- 1997-08-14 PT PT97943809T patent/PT922034E/pt unknown
- 1997-08-14 EA EA199900121A patent/EA001704B1/ru not_active IP Right Cessation
- 1997-08-14 US US09/147,568 patent/US6479488B1/en not_active Expired - Fee Related
- 1997-08-14 CN CN97197233A patent/CN1131214C/zh not_active Expired - Fee Related
- 1997-08-14 DE DE69714265T patent/DE69714265T2/de not_active Expired - Lifetime
- 1997-08-14 ZA ZA977326A patent/ZA977326B/xx unknown
- 1997-08-14 AU AU45518/97A patent/AU724473B2/en not_active Ceased
- 1997-08-14 CA CA002264118A patent/CA2264118C/en not_active Expired - Fee Related
- 1997-08-30 TW TW086112442A patent/TW449582B/zh not_active IP Right Cessation
-
1999
- 1999-01-22 IS IS4953A patent/IS4953A/is unknown
- 1999-02-16 NO NO19990723A patent/NO312241B1/no not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0922034T3 (da) | Tetrahydroquinolinderivater som EAA-antagonister | |
NO20013003D0 (no) | Kinolin-derivater | |
ATE228505T1 (de) | Chinolinderivate | |
ATE250036T1 (de) | Chinolinderivate | |
NO965036D0 (no) | Kinolinderivater som techykinin NK3 reseptor-antagonister | |
ATE236155T1 (de) | Naphthyridin-derivate | |
DK1140935T3 (da) | 1,2-anellerede quinolinderivater | |
ATE261942T1 (de) | 6-phenylpyridinderivate | |
IS4800A (is) | Nýjar 19-nor-pregnene afleiður | |
ATE229005T1 (de) | Chinolinderivate | |
NO991384D0 (no) | Substituerte heterocykler som anti-tumormidler | |
NO974043L (no) | Indolderivater som EAA-antagonister | |
ATE255098T1 (de) | Substituierte chromanderivate | |
NO991560D0 (no) | PDE IV som inhiberer 2-cyanoiminoimidazol-derivater | |
ATE255099T1 (de) | Substituierte chromanderivate | |
DK0854867T3 (da) | Tetrahydroquinoliner som NMDA-antagonister | |
DK1086093T3 (da) | Tetrahydroquinolinderivater som glycinantagonister | |
PT931087E (pt) | Novos derivados de piranosido | |
FI970143A (fi) | Kinoliinijohdannaiset leukotrieeniantagonisteina | |
ATA69896A (de) | 3-methylimino-3-cephemderivate 3-methylimino-3-cephemderivate |